dermatology-conference-2016_keynote

3 / 6

Volume 7 Issue 8(Suppl) J Clin Exp Dermatol Res
ISSN: 2155-9554 JCEDR, an open access journal
Page 20
Dermatology Conference 2016
November 28-29, 2016
conferenceseries.com
November 28-29, 2016 Melbourne, Australia
10th Asia-Pacific Dermatology Conference
Patrik J Tosenovsky, J Clin Exp Dermatol Res 2016, 7:8(Suppl)
Endovascular Deep Vein Reconstruction improves Leg Ulcer Healing
The aim of this study was to analyse how safe and reliable is iliac vein stenting in patients with non-thrombotic iliac/
femoral vein lesions. Prospectively maintained database of 50 consecutive patients was analysed. Total 53 iliac veinswere
stentedfor non-thrombotic lesions (compression of iliac vein) between 2011-16. Patients suffered from variety of symptoms
including intractable swelling (C3), healed ulcers/lipodermatosclerosis (C4), active venous ulcer (C5), venous claudications
or a combination of symptoms. Patients median age was 72 years (range 22-90), male to female ration 21:29, median follow
up was 8.2 months (range 1 to 36 months). Perioperative mortality was 0%, surgical complication rate in 30 days was 2 % (1
stent thrombosed; primary stent patency rate was 96%), 2 patients developed a non-surgical complication during first 30 days.
Sixty eight percent of patients with active leg venous ulcer (C6) healed within 12 weeks post intervention.
Conclusion: Non-thrombotic iliac vein lesion stenting is safe and reliable and it might be suitable for selected group of patients
with advanced skin changes due to venous hypertension.
Biography
Vascular and Endovascular surgeon, Patrik J. Tosenovsky provides services for all vascular patients, sub-specialising in chronic venous disease, diabetic foot and
vascular access. Patrik performs sub-specialty procedures including; deep vein reconstructions through keyhole surgery for patients with severe post-thrombotic
syndrome, surgical management of extensive DVT, laser and sclerotherapy for varicose veins, micro-vascular procedures, including free tissue transfer for non-
healing ulcers.Trained in Europe as a vascular and transplant surgeon, Patrik has practiced as a consultant since 2000. He holds a fellowship from the European
Board of Vascular Surgeons, which he completed in Amsterdam, and a PhD in diabetic foot. He completed his FRACS in Sydney. Patrik has always been active in
research and teaching at both undergraduate and postgraduate levels. He is currently participating in an early stage clinical study in Western Australia that will look
at innovative diagnostic tools for arteriovenous fistulas for patients on haemodialysis.
Patrik J Tosenovsky
University of Western Australia, Australia